Clemastine Fumarate: clinical trials recruiting now

Fewer than 3 recruiting trials found.

2

Recruiting trials

9

Conditions studied

2

US states with sites

1

Countries

Phase breakdown

Phase 1 1 Phase 2 2

Conditions being studied

Condition	Trials
Depression	1
Multiple Sclerosis (MS)	1
Multiple Sclerosis Benign	1
Multiple Sclerosis Brain Lesion	1
Multiple Sclerosis Relapse	1
Multiple Sclerosis, Chronic Progressive	1
Multiple Sclerosis, Primary Progressive	1
Multiple Sclerosis, Relapsing-Remitting	1
Multiple sclerosis	1

Recruiting trials involving Clemastine Fumarate

Assessing Changes in Multi-parametric MRI in MS Patients Taking Clemastine Fumarate as a Myelin Repair Therapy
NCT05359653 · Phase: Phase 1, Phase 2 · Ages: 18 Years to 55 Years · Sex: All (male and female) · 1 location
Clemastine for Improving White Matter and Boosting Antidepressant Response in Late-life Depression
NCT06591091 · Phase: Phase 2 · Ages: 60 Years and older · Sex: All (male and female) · 1 location

Common questions

How many recruiting trials involve Clemastine Fumarate?

2 recruiting trials across 9 conditions.

Is this list of trials complete?

No. For the full record, search ClinicalTrials.gov.

Get notified when new trials open

One email when new recruiting trials are added. Unsubscribe anytime.